A Study of Multiple Oral Doses of IX-01 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

October 31, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

Placebo

Administered orally

DRUG

IX-01

Administered orally

Trial Locations (1)

Hammersmith Medicines Research, London

All Listed Sponsors

lead

Ixchelsis Limited

INDUSTRY

NCT02792647 - A Study of Multiple Oral Doses of IX-01 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter